1. Home
  2. ASTE vs XNCR Comparison

ASTE vs XNCR Comparison

Compare ASTE & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astec Industries Inc.

ASTE

Astec Industries Inc.

HOLD

Current Price

$45.59

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$15.55

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTE
XNCR
Founded
1972
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
ASTE
XNCR
Price
$45.59
$15.55
Analyst Decision
Hold
Buy
Analyst Count
1
10
Target Price
$41.00
$22.78
AVG Volume (30 Days)
164.8K
726.1K
Earning Date
11-05-2025
11-05-2025
Dividend Yield
1.12%
N/A
EPS Growth
N/A
N/A
EPS
2.08
N/A
Revenue
$1,368,800,000.00
$150,132,000.00
Revenue This Year
$8.19
$18.81
Revenue Next Year
$6.23
N/A
P/E Ratio
$22.26
N/A
Revenue Growth
6.66
38.16
52 Week Low
$29.65
$6.92
52 Week High
$50.83
$25.52

Technical Indicators

Market Signals
Indicator
ASTE
XNCR
Relative Strength Index (RSI) 51.58 45.69
Support Level $45.72 $16.44
Resistance Level $47.56 $17.18
Average True Range (ATR) 1.44 0.96
MACD 0.17 -0.31
Stochastic Oscillator 49.62 0.63

Price Performance

Historical Comparison
ASTE
XNCR

About ASTE Astec Industries Inc.

Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. It has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Share on Social Networks: